ARS Pharmaceuticals, Inc.

AssuredPartners Investment Advisors, LLC SPRY

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/10/2026

Shares

76,210

Value ($000)

639

Weight

0.1%

2025 Q2 - 2026 Q1 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/10/2026	639	0.1%	76,210	3/31/2026
2025 Q4	2/3/2026	883	0.1%	75,779	12/31/2025
2025 Q3	10/6/2025	581	0.1%	57,785	9/30/2025
2025 Q2	7/29/2025	994	0.2%	56,969	6/30/2025